What Is the Clavicular Peptide Stack? Every Compound Explained
The complete breakdown of Clavicular's viral looksmaxxing peptide protocol — Retatrutide, BPC-157, GHK-CU, and SNAP-8.
What Is the Clavicular Peptide Stack?
The Clavicular peptide stack is a research compound protocol popularized by Clavicular — a social media figure known for documenting extreme body recomposition using research peptides. The stack gained viral attention for two reasons: the clinical data behind its core compound (Retatrutide, -28.7% body weight in Phase 2) and Clavicular's systematic, documented approach to stacking compounds for multiple concurrent effects.
The Core Philosophy
The Clav stack is built on a layered approach:
- Maximum fat loss via the most potent GLP compound available
- GI protection because aggressive GLP protocols are hard on the gut
- Skin quality maintenance because extreme leanness exposes skin quality
- Advanced aesthetics for facial and skin optimization
Compound 1: Retatrutide (GLP-3 R)
Retatrutide is a triple GLP-1/GIP/Glucagon receptor agonist — the most potent GLP compound in clinical research. The glucagon receptor addition drives direct hepatic fat oxidation and brown adipose thermogenesis, adding a third fat-burning mechanism beyond appetite suppression.
Phase 2 data at 8mg/week over 48 weeks: −28.7% body weight. Nothing else in the GLP class comes close.
Compound 2: BPC-157
BPC-157 is a 15-amino acid peptide derived from gastric juice. Clavicular runs it specifically to counteract the GI side effects of Retatrutide — nausea, altered gut motility, and GI stress during dose escalation. 36+ preclinical studies support its gastroprotective mechanism.
Compound 3: GHK-CU (GLOW)
When you lose 28% of your body weight, your skin has to adapt to a new frame. GHK-CU upregulates 4,000+ genes involved in collagen synthesis and skin remodeling. Clavicular calls it the GLOW protocol — it's the aesthetic layer that makes extreme leanness look impressive rather than aged.
Compound 4: SNAP-8 (KLOW)
The advanced skin layer. SNAP-8 inhibits SNARE complex signaling at the NMJ, reducing expression muscle contraction force. Preclinical models show up to 63% wrinkle depth reduction.
Is the Clav Stack Real?
All compounds in the stack have legitimate preclinical research behind them. Retatrutide has Phase 2 human clinical data. The stack is built on published research, not anecdote — which is why it attracted attention beyond typical looksmaxxing communities.
All products are for research purposes only. Not intended for human use.
Shop the Clav Protocol
Research-grade Retatrutide, BPC-157, GHK-CU, SNAP-8 from Apollo Peptide Sciences — every compound in the Clavicular protocol.
Related Products

GLP-3 R 15mg
Retatrutide (GLP-3 R) 15mg — the standard Clav stack supply. Clavicular's primary fat loss compound. Triple GLP-1/GIP/Glucagon receptor agonist. Phase 2 data: −28.7% body weight at 48 weeks. Most popular vial size. >98% purity.
CAS: 2381609-35-2

GHK-CU 50mg
GHK-CU (copper peptide) 50mg — Clavicular's GLOW peptide. Upregulates 4,000+ genes involved in collagen synthesis, skin remodeling, and angiogenesis. Counteracts skin quality loss during aggressive fat loss. The aesthetic layer of the Clav stack. >98% purity.
CAS: 49557-75-7
More Research Articles
Retatrutide vs Tirzepatide vs Semaglutide: Why Clav Chose Triple-Agonist
Data comparison of all three GLP generations. Why the Clavicular stack uses Retatrutide over tirzepatide and semaglutide.
Why BPC-157 Is Non-Negotiable When Running Retatrutide
The gut science behind running BPC-157 alongside every GLP protocol. What GLP peptides do to your GI tract and how BPC-157 addresses it.
GHK-CU Deep Dive: The Science Behind the GLOW Peptide
Why GHK-CU is the most researched injectable skin peptide and why Clavicular calls it the GLOW protocol.
